跳至主要内容
临床试验/NCT02215213
NCT02215213已完成不适用

Assessment of Dose Effectiveness of Vitamin D Supplementation During Pregnancy

Aga Khan University1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
350
试验地点
1
主要终点
pregnancy out come

研究概览

简要总结

The study is randomized blinded trial of Vitamin D supplementation to pregnant women; the study participants will receive Vitamin D in supplement form. Pregnant women will be individually randomized to three groups receiving a dose of 400, 2000 and 4000 IU/ day till the time of delivery.A blood sample will also be collected from the participant at the time of recruitment /before the starting of the supplementation for the assessment of Calcium, Phosphorus, Alkaline Phosphatase and Vitamin D levels. The second blood sample for vitamin D level to assess vitamin D status will be done after completion of the supplementation phase at the time of delivery (till 48 hours of delivery). The samples will be sent to Aga Khan University laboratory

详细描述

The investigators hypothesize that Pakistani mothers as darkly pigmented, will require substantially higher oral supplementation with vitamin D to replenish the micronutrient stores and aid to resolve associated maternal and neonatal morbidity due to Vitamin D deficiency. The investigators expect that if vitamin D is supplemented to pregnant women, their newborn infants would inevitably replenish the micronutrient stores and aid to resolve the maternal and neonatal morbidity due to Vitamin D deficiency.This is hospital based double blinded trial, study participants divided into three groups which will receive Vitamin D supplementation in 400, 2000 and 4000 International Units. The group which will receive 400 IUs will be treated as control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women aged 15 - 45 years
  • Less than 16 weeks pregnant from Last menstrual period.
  • Agree to take part in this study, will be enrolled.

排除标准

  • Pregnant women with pre existing type 1 or type II diabetes,
  • Pregnant women with pre existing hypertension
  • Women with multiple fetuses, babies (twins, triplets)
  • Women with fetal anomaly in scan
  • Refuse to participate in the study

研究组 & 干预措施

Intervention Group

Active Comparator

Arm 1 is receiving vitamin D supplementation in 2000 IU/day ,

干预措施: Vitamin D supplement (Drug)

Arm 2 intervention group

Active Comparator

Arm 2 is receiving vitamin D supplementation in 4000/IU per day

干预措施: Vitamin D supplement (Drug)

Arm 3 control group

Active Comparator

Arm 3 is receiving vitamin D supplementation in 400 IU/day

干预措施: Vitamin D supplement (Drug)

结局指标

主要结局

pregnancy out come

时间窗: At delivery of neonate

Hypovitaminosis, Pre eclampsia, Preterm labour, preterm birth, low birth weight, Still birth rates.

次要结局

  • Prevalence of vitamin D deficiency in pregnant women(at recruitment into study (first trimester))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Sidrah Nausheen

Principal Investigator

Aga Khan University

研究点 (1)

Loading locations...

相似试验